EUVIMEDEUVIMED entdecken
Crossref

Who does not benefit from our national breast screening programme and who should have oversight?

Ineke Meredith, Ross Lawrenson

New Zealand Medical Journal · 2023

DOI: 10.26635/6965.6234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New Zealand Medical Journal, 2023. Verfasst von Ineke Meredith und 1 weiteren Autor:innen. Beteiligte Einrichtung: Breast & General Surgeon, Paris Breast Centre, France. Hauptthemen laut MEDLINE: Mass Screening, Breast Neoplasms.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The recent report on the delays for mammography encountered by women in the Wellington Region reminds us that the organisation of cancer screening is far from straightforward, and we highlight these complexities in our viewpoint article. Screening can reduce mortality from cancer, but it is costly, and the benefits are many years in the future. Cancer screening can result in some individuals being over-diagnosed and over-treated, can impact on the services for symptomatic patients and can exacerbate inequities. Reviewing the quality, safety and acceptability of our breast screening programme is important but there is a need to acknowledge the role of the resulting clinical services, including the opportunity cost to symptomatic patients who seek healthcare in the same system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mass ScreeningBreast NeoplasmsFemaleHumansNew ZealandMammographyDelivery of Health CareEarly Detection of Cancer

Autor:innen und Institutionen

  • Breast & General Surgeon, Paris Breast Centre, France.
  • Medical Research Centre, The University of Waikato, Hamilton, New Zealand; Strategy and Funding, Waikato Hospital, Hamilton, New Zealand.

Zitieren

APA

Meredith, I., & Lawrenson, R. (2023). Who does not benefit from our national breast screening programme and who should have oversight?. New Zealand Medical Journal. https://doi.org/10.26635/6965.6234

Vancouver

Meredith I, Lawrenson R. Who does not benefit from our national breast screening programme and who should have oversight?. New Zealand Medical Journal. 2023. doi:10.26635/6965.6234

BibTeX
@article{Meredith2023,
  author = {Meredith, Ineke and Lawrenson, Ross},
  title = {Who does not benefit from our national breast screening programme and who should have oversight?},
  journal = {New Zealand Medical Journal},
  year = {2023},
  doi = {10.26635/6965.6234}
}
Kostenlos starten →